IdentificationGeneric Name(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACIDDrugBank Accession NumberDB08007BackgroundNot AvailableTypeSmall MoleculeGroupsExperimentalStructure


3DDownload MOLSDF3D-SDFPDBSMILESInChI


 Similar StructuresStructure for (2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID (DB08007)× CloseWeightAverage: 238.2399 Monoisotopic: 238.095356946 Chemical FormulaC11H14N2O4SynonymsNot AvailablePharmacologyIndicationNot AvailableReduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.See how  Build, train, & validate predictive machine-learning models with structured datasets.See howContraindications & Blackbox WarningsAvoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Learn more  Avoid life-threatening adverse drug events & improve clinical decision support.Learn morePharmacodynamicsNot AvailableMechanism of actionTargetActionsOrganismUChymotrypsin-like elastase family member 1Not AvailableHumansAbsorptionNot AvailableVolume of distributionNot AvailableProtein bindingNot AvailableMetabolismNot AvailableRoute of eliminationNot AvailableHalf-lifeNot AvailableClearanceNot AvailableAdverse EffectsImprove decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Learn more  Improve decision support & research outcomes with our structured adverse effects data.Learn moreToxicityNot AvailablePathwaysNot AvailablePharmacogenomic Effects/ADRs 


Not AvailableInteractionsDrug Interactions 


This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist. Not AvailableFood InteractionsNot AvailableCategoriesDrug CategoriesNot AvailableChemical TaxonomyProvided by ClassyfireDescriptionThis compound belongs to the class of organic compounds known as benzene and substituted derivatives. These are aromatic compounds containing one monocyclic ring system consisting of benzene.KingdomOrganic compoundsSuper ClassBenzenoidsClassBenzene and substituted derivativesSub ClassNot AvailableDirect ParentBenzene and substituted derivativesAlternative ParentsMonosaccharides / Alpha hydroxy acids and derivatives / Ureas / Secondary alcohols / Monocarboxylic acids and derivatives / Carboxylic acids / Organopnictogen compounds / Organonitrogen compounds / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds


 show 1 moreSubstituentsAlcohol / Alpha-hydroxy acid / Aromatic homomonocyclic compound / Carbonic acid derivative / Carbonyl group / Carboxylic acid / Carboxylic acid derivative / Hydrocarbon derivative / Hydroxy acid / Monocarboxylic acid or derivatives / Monocyclic benzene moiety / Monosaccharide / Organic nitrogen compound / Organic oxide / Organic oxygen compound / Organonitrogen compound / Organooxygen compound / Organopnictogen compound / Secondary alcohol / Urea


 show 10 moreMolecular FrameworkAromatic homomonocyclic compoundsExternal DescriptorsNot AvailableAffected organismsNot AvailableChemical IdentifiersUNIINot AvailableCAS numberNot AvailableInChI KeyKGFDIRSBGRVEFZ-SECBINFHSA-NInChIInChI=1S/C11H14N2O4/c14-9(10(15)16)7-13-11(17)12-6-8-4-2-1-3-5-8/h1-5,9,14H,6-7H2,(H,15,16)(H2,12,13,17)/t9-/m1/s1IUPAC Name(2R)-3-[(benzylcarbamoyl)amino]-2-hydroxypropanoic acidSMILES[H][C@@](O)(CNC(=O)NCC1=CC=CC=C1)C(O)=OReferencesGeneral ReferencesNot AvailableExternal LinksPubChem Compound24820112PubChem Substance99444478ChemSpider25057879PDBe LigandJ54PDB Entries2v35Clinical TrialsClinical Trials 


PhaseStatusPurposeConditionsCountPharmacoeconomicsManufacturersNot AvailablePackagersNot AvailableDosage FormsNot AvailablePricesNot AvailablePatentsNot AvailablePropertiesStateSolidExperimental PropertiesNot AvailablePredicted PropertiesPropertyValueSourceWater Solubility1.08 mg/mLALOGPSlogP-0.25ALOGPSlogP-0.19ChemaxonlogS-2.3ALOGPSpKa (Strongest Acidic)3.67ChemaxonpKa (Strongest Basic)-2.1ChemaxonPhysiological Charge-1ChemaxonHydrogen Acceptor Count4ChemaxonHydrogen Donor Count4ChemaxonPolar Surface Area98.66 Å2ChemaxonRotatable Bond Count5ChemaxonRefractivity59.67 m3·mol-1ChemaxonPolarizability23.78 Å3ChemaxonNumber of Rings1ChemaxonBioavailability1ChemaxonRule of FiveYesChemaxonGhose FilterYesChemaxonVeber's RuleNoChemaxonMDDR-like RuleNoChemaxonPredicted ADMET FeaturesPropertyValueProbabilityHuman Intestinal Absorption-0.5199Blood Brain Barrier-0.6474Caco-2 permeable-0.7423P-glycoprotein substrateNon-substrate0.5908P-glycoprotein inhibitor INon-inhibitor0.9133P-glycoprotein inhibitor IINon-inhibitor0.9257Renal organic cation transporterNon-inhibitor0.9399CYP450 2C9 substrateNon-substrate0.7536CYP450 2D6 substrateNon-substrate0.7993CYP450 3A4 substrateNon-substrate0.803CYP450 1A2 substrateNon-inhibitor0.8787CYP450 2C9 inhibitorNon-inhibitor0.885CYP450 2D6 inhibitorNon-inhibitor0.945CYP450 2C19 inhibitorNon-inhibitor0.8973CYP450 3A4 inhibitorNon-inhibitor0.9092CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9743Ames testNon AMES toxic0.6994CarcinogenicityNon-carcinogens0.927BiodegradationReady biodegradable0.7651Rat acute toxicity1.7733 LD50, mol/kg Not applicablehERG inhibition (predictor I)Weak inhibitor0.9446hERG inhibition (predictor II)Non-inhibitor0.9112  ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397) SpectraMass Spec (NIST)Not AvailableSpectraSpectrumSpectrum TypeSplash KeyPredicted GC-MS Spectrum - GC-MSPredicted GC-MSNot AvailablePredicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot AvailablePredicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot AvailableTargetsBuild, predict & validate machine-learning modelsUse our structured and evidence-based datasets to unlock newinsights and accelerate drug research.Learn more  Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.Learn more


 Details1. Chymotrypsin-like elastase family member 1KindProteinOrganismHumansPharmacological actionUnknownGeneral FunctionSerine-type endopeptidase activitySpecific FunctionActs upon elastin.Gene NameCELA1Uniprot IDQ9UNI1Uniprot NameChymotrypsin-like elastase family member 1Molecular Weight27797.995 DaReferencesBerman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article] ×Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice. Learn more   Drug created at September 15, 2010 21:27 / Updated at June 12, 2020 16:52 